Dentsu Health Continues to Bolster its Strategic & Analytical Capabilities with Key Senior Hires
On May 10, 2022, dentsu health announced two senior appointments aimed at enhancing its capabilities. Olympia Mantsios has been appointed Global VP Data & Analytics, focusing on research and audience insights. Lynda Gordon joins as SVP, Product Development, tasked with accelerating product transformation. These strategic hires are part of dentsu's goal to unlock growth opportunities across the healthcare sector. Dentsu health utilizes over 2,000 experts to innovate healthcare marketing services.
- Appointment of Olympia Mantsios as Global VP Data & Analytics to enhance research capabilities.
- Hiring of Lynda Gordon as SVP, Product Development to accelerate product transformation.
- None.
About dentsu international
Part of dentsu, dentsu international is made up of six leadership brands - Carat, dentsu X, iProspect, Isobar, dentsumcgarrybowen, Merkle, and supported by its specialist brands.
About dentsu health
Dentsu health is an integrated solution that is transforming the healthcare agency services model through a global teaming platform of 2,000+ experts, specializing in health, wellness and pharmaceutical marketing.
Dentsu health unites leadership across our global agency brands in data and technology with a deep understanding of the emotional territory of healthcare, equips brands to connect with the right audience at the right moment, but always with ideas that speak to the heart. https://dentsuhealth.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510006031/en/
For more information reach out to:
Source:
FAQ
What is the significance of dentsu health's recent appointments?
Who are the new key hires at dentsu health?
What is dentsu health's focus with these new appointments?
How many experts does dentsu health employ?